angioedema

(redirected from hae)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.

angioedema

[‚an·jē·ō·i′dē·mə]
(medicine)
The development of giant hives beneath the surface of the skin, especially around the eyes and lips; usually due to an allergic response.
References in periodicals archive ?
This study was designed to determine the prevalence and occurrence of clinical manifestations of hereditary angioedema (HAE) in previously unevaluated blood relatives of known (index) patients with HAE in a few villages of a city in a province (Duzce) in Turkey.
amp;nbsp;Earlier in the episode, Lady Hae had asked Wook to either take a second wife or divorce her so she can die peacefully, telling him that she knows he doesn't love her.
In HAE type I, a gene mutation results in decreased plasma antigenic and functional levels of C1INH, which affect 85% of patients.
HAE is caused by a deficiency of the C1 esterase inhibitor protein, which is present in blood and helps control inflammation (swelling) and parts of the immune system.
Patient who presents with gastrointestinal symptoms of HAE without skin edema is rare and can be hard to identify during a host of acute abdomens as in this case.
Based upon the attributes of selectivity, specificity and long half-life Dyax has chosen to develop DX-2930 as a self-administered, subcutaneous injection for chronic prevention of HAE attacks.
This article aims to provide an overview of the pathologic features and clinical presentation of HAE, with a view toward improving the differential diagnosis and enhancing effective management.
After years of debate about whether angioedema is caused by activation of the complement or the contact systems, it is now generally agreed that bradykinin is probably the only mediator of angioedema attacks in HAE (9).
Flower of Scotland is triumphalist, set after the battle, whereas Scots Wha Hae is set prior to the battle in which the protagonist is willing to die for freedom.
The trial, referred to as EDEMA1 (Evaluating DX-88's Effects on Mitigating Angioedema), was designed to assess the efficacy and safety of DX-88 in the treatment of all forms of acute attacks of HAE, including peripheral, abdominal and laryngeal attacks.
M2 EQUITYBITES-October 26, 2017-EC approves label extension of Shire's FIRAZYR for symptomatic treatment of HAE attacks in paediatric patients
M2 PHARMA-October 26, 2017-EC approves label extension of Shire's FIRAZYR for symptomatic treatment of HAE attacks in paediatric patients